Despite these important functions in GBM stem cells, these two ADAM proteases do not seem to be clinically relevant, as their expression levels are not (ADAM10) or even positively (ADAM17) correlated with GBM patient survival, as extracted from TCGA datasets. The gene discussed is ADAM10; the disease is glioblastoma.